This is an archived programme
We are supporting national ambitions to improve cholesterol management and the identification and management of familial hypercholesterolaemia (FH). FH is a genetic condition causing elevated cholesterol levels from birth; it is associated with a significantly increased risk of premature cardiovascular disease, which can be reduced by early detection and effective treatment.
HINWC has supported the setting up of the commissioned FH Service in Cheshire and Merseyside (C&M). The C&M FH service has been in operation since September 2022, providing a referral pathway for regional teams to identify possible FH through genetic testing and cascade testing for first degree relatives if FH is diagnosed. For patients there is a dedicated website about the FH Service to learn more about this condition and the service itself.
Listen to a 2023 Health Innovation North West Coast podcast with FH patient Simon Clarke, and watch Simon in this film by Liverpool Heart and Chest Hospital below.
Podcast
Video